Cargando…
Where the metabolome meets the microbiome for pancreatic cancer detection
Risk prediction tools for pancreatic cancer are urgently sought to facilitate screening. Irajizad et al.(1) describe the performance of a risk predication model based on circulating microbial- and non-microbial metabolites for assessment of 5-year pancreatic cancer risk.
Autores principales: | Oldfield, Lucy, Costello, Eithne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518497/ https://www.ncbi.nlm.nih.gov/pubmed/37729875 http://dx.doi.org/10.1016/j.xcrm.2023.101011 |
Ejemplares similares
-
Where are all the guns? Modeling firearm ownership in the United States
por: Wahl, Jonas
Publicado: (2022) -
Toward hypothesis-driven, personalized microbiome screening
por: Sedrani, Catherine, et al.
Publicado: (2022) -
Like mother, like child: The maternal microbiome impacts offspring asthma
por: Tarrant, Isabel, et al.
Publicado: (2022) -
Get rid of pancreatic cancer by inhibiting garbage disposal?: Comment on “UAE1 Inhibition mediates the unfolded protein response, DNA damage and caspase-dependent cell death in pancreatic cancer” by Rehemtulla et al
por: Geismann, Claudia, et al.
Publicado: (2020) -
A large-scale organoid-based screening platform to advance drug repurposing in pancreatic cancer
por: Mainardi, Sara, et al.
Publicado: (2022)